Vitamin B and Choline Supplements Could Slow Glaucoma Progression, Mouse Study Finds

New research suggests that vitamin B and choline supplements may slow the progression of glaucoma. A mouse study shows promising potential for nutritional interventions in eye health.
Vitamin B and Choline Supplements Could Slow Glaucoma Progression, Mouse Study Finds

Two supplements may help slow down the progression of glaucoma, according to recent research.
Glaucoma is a group of eye diseases that can damage the optic nerve and potentially cause blindness. While there is no cure yet, treatments aim to slow its progression. Previous studies suggest that a healthy diet rich in certain nutrients can lower risk, including omega-3 fatty acids, vitamins B3, A, C, and antioxidants like lutein and zeaxanthin.
A new study published in Cell Reports Medicine indicates that supplementation with B vitamins and choline may help slow glaucoma progression, based on mouse models. Researchers focused on how these nutrients impact the retina and optic nerve health.
Study Highlights:
- The study examined the role of homocysteine, an amino acid involved in protein synthesis, which in high levels has been linked to health issues and eye disease progression.
- Surprisingly, elevated homocysteine did not worsen glaucoma in mice, suggesting it may be a bystander rather than a direct cause.
- Supplementation with B6, B9 (folate), B12, and choline was shown to halt or slow optic nerve damage, even in aggressive glaucoma models.
- The effect appears to be independent of intraocular pressure, a common target in glaucoma treatment.
- Researchers are now planning clinical trials to explore these findings in humans.
Expert Opinions:
- Dr. David Geffen notes that supplementing with vitamins could be a groundbreaking adjunct therapy, especially since glaucoma has no cure and treatments can become less effective.
- Dr. Benjamin Bert emphasizes that any discovery helping to prevent or slow glaucoma is promising, especially with increasingly aging populations.
This research opens new avenues for managing glaucoma through nutritional support, offering hope for non-invasive, accessible interventions.
For more information, read the full study here.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Neural Basis of Social Hierarchy Identified in Squirrel Monkeys
A new study uncovers the neural mechanisms behind social dominance in squirrel monkeys, highlighting the role of the uncinate fasciculus in social hierarchy and aggression, with implications for human social behavior.
Australia's Gambling Harm Underreported as Regulatory Failures Persist
Investigations reveal that Australia's gambling-related harm, including suicides, is underreported, and regulatory failures continue to exacerbate the crisis. Urgent reforms are needed to protect vulnerable populations.
New Advances in Breast Cancer Treatment: Targeting EPIC1 to Overcome Immunotherapy Resistance
Scientists have discovered that suppressing the long noncoding RNA EPIC1 can reverse resistance to immunotherapy in breast cancer, offering new hope for effective treatments. Researchers highlight EPIC1's role in immune evasion and its potential as a therapeutic target when combined with immunotherapies like pembrolizumab.
Establishing a National Standard for Safe and Scalable AI in Healthcare
Duke University researchers have developed pioneering frameworks to evaluate the safety and performance of AI models in healthcare, advancing responsible AI adoption with scalable assessment tools for clinical settings.



